Sharp investors are usually looking for true bargains in the stock market. Finding these stocks can help give the stock portfolio a boost. Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) have come into focus recently. Checking in on the stock, we can see that it has been trading near the $7.86 level. Going forward, the investment community will be closely monitoring shares looking for signs of positive momentum. Investors will often follow the current stock price relative to its 52-week high and low levels. The 52-week high is presently 13.69, and the 52-week low is sitting at 4.36. When the stock is trading near the 52-week high or 52-week low, investors may pay increased attention to see if there will be a move through that level. Scanning back over the past 12 weeks, the stock has moved 8.86%. Heading back to the beginning of the calendar year, we can see that shares have changed 18.37%. Over the last 4 weeks, shares have seen a change of 53.52%. Over the last 5 sessions, the stock has moved 23.78%.
When examining stocks, investors might be doing top down research. Top down analysis begins with looking at certain macro-economic factors. This may involve focusing in on the bigger picture and going all the way down to specific stocks. Starting at the top, investors may check on the global economic environment, overall market trends, and sector trends. Investors may choose to start doing research the other way around. This may involve first looking at the fundamentals for particular stocks in order to gauge the strength from a company standpoint. Many investors will scope out all the different investing aspects as to not leave any information uncovered.
Sell-side analysts have the capability of providing stock ratings for companies that they cover. According to analysts polled by Zacks Research, the current average broker rating on shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is 2.2. This average rating includes analysts who have offered Sell, Buy and Hold ratings on the stock. This rating falls on a numeric scale from 1 to 5. A score of 1 would indicate a Buy recommendation, and a score of 5 would represent a Sell recommendation. Out of all the analysts offering ratings, 3 have pegged the stock a Strong Buy or Buy, based on data provided by Zacks Research.
Tracking the current quarter consensus EPS estimate for Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), we have noted that the number is currently -0.21. This estimate is using 1 contributing analysts polled by Zacks Research. For the last quarter, the company posted a quarterly EPS of -0.16. Sell-side Wall Street analysts study companies and provide their opinions of where the stock might be going in the future. A lot of weight is given to analyst estimates, and earnings beats or misses revolve around these predictions. Sometimes these estimates are very close to the actual, and other times they are not. When a company announces actual earnings results, a large surprise factor can result in increased volatility. If a company beats estimates and posts a positive earnings surprise, the stock may see a near-term bump in price. On the flip side, a negative surprise may move the stock lower. Based on the unknown, many investors may choose to trade with caution around earnings releases.
Analysts have set a target price on shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX). The current consensus price target is $18.1. Wall Street analysts often provide price target projections on stocks that they cover. Price target projections can be created using a wide variety of methods. Many investors will closely track stock target prices, especially when analysts make updates. A thorough research report will generally offer detailed reasoning for a certain target projection. Some investors may watch sell-side targets very closely and use the information to help with their own stock research.
Investors may be trying to figure out what stocks will give a boost to portfolio performance over the next few months. Value investors may be looking for current value in the market. They are generally looking for bargains and interested in uncovering those stocks that may be primed for a run but have fallen out of favor with Wall Street. Growth investors may be looking to target companies that are able to advance earnings faster than average. This may include searching for those industries that have strong growth trends and a proven track record of strong sales and earnings growth.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.